Person

Gail Boudreaux

President and CEO · Director, Elevance Health

Current S&P 500 boards
2
Current roles
2
Open-market buys
$5.7M
Open-market sales
$17.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 17, 2026ELVBuy680$366.41$249K
Jul 17, 2026ELVBuy2,045$368.25$753K
Jul 18, 2025ELVBuy2,334$286.07$668K
Jul 18, 2025ELVBuy5,116$287.12$1.5M
Jul 18, 2025ELVBuy1,050$287.96$302K
Jul 22, 2024ELVSale1,000$503.67$504K
Jul 22, 2024ELVSale2,250$502.23$1.1M
Jul 22, 2024ELVSale6,621$501.40$3.3M
Jul 22, 2024ELVSale2,250$504.27$1.1M
Jul 22, 2024ELVSale1,100$498.50$548K
Jul 22, 2024ELVSale20,779$500.36$10.4M
Jan 30, 2020ELVBuy5,600$263.52$1.5M
Jan 30, 2020ELVBuy2,000$264.22$528K
Feb 5, 2019ZBHBuy2,095$119.33$250K

SEC reporting-owner ID (CIK) 1287920 · all filings on EDGAR